Agios Pharmaceuticals, Inc. AGIO 深 沪
等待开盘 08-25 09:30:00 美东时间
32.64
-0.450
-1.36%
华盛通- 最 高33.25
- 今 开33.25
- 成交量 63.57万股
- 最 低 32.61
- 昨 收 33.09
- 总市值 19.49亿
- 52周最高 46.00
- 市盈率 静 --
- 换手率 1.06%
- 52周最低 22.24
- 委 比 9.49%
- 总股本 5970.19万
- 历史最高 138.85
- 量 比 0.62
- 振 幅 1.93%
- 历史最低 15.77
- 每 手 1
- 风险率 5.71%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 花旗下调美光科技目标价从1400美元降至1150美元；爱彼迎、Datadog、Cloudflare、Etsy、Natera、拉夫劳伦获多家大行上调目标价
今日重点评级关注：康托·菲茨杰拉德：维持InflaRx"超配"评级，目标价从4美元升至6美元；RBC Capital：维持Nuvation Bio"跑赢大市"评级，目标价从19美元升至20美元
08-10 19:24
JP Morgan Maintains Neutral on Agios Pharmaceuticals, Raises Price Target to $34
JP Morgan analyst Tessa Romero maintains Agios Pharmaceuticals (NASDAQ:AGIO) with a Neutral and raises the price target from $31 to $34.
08-07 23:36
美股大行评级 | 绩后重锤！Meta惨遭16家大行下调目标价；高通、Arm、泛林集团、波士顿科学也遭多家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持TOMI Environmental Solutions"买入"评级，目标价从3.5美元升至7美元；Canaccord Genuity：维持Viking Therapeutics"买入"评级，目标价从107美元升至114美元
07-31 11:43
HC Wainwright & Co. Maintains Buy on Agios Pharmaceuticals, Raises Price Target to $55
HC Wainwright & Co. analyst Emily Bodnar maintains Agios Pharmaceuticals (NASDAQ:AGIO) with a Buy and raises the price target from $52 to $55.
07-31 03:34
美股大行评级 | 富国银行上调亚马逊目标价从313美元升至322美元；潜在涨幅370.99%！HC Wainwright上调Greenwich LifeSciences目标价至69美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Greenwich LifeSciences"买入"评级，目标价从50美元升至69美元；高盛：维持Taysha Gene Therapies"买入"评级，目标价从11美元升至13美元
07-22 11:35
Agios Reports Neutral Sickle Cell Data, Decides To Stop Development
Agios Pharmaceuticals Inc. (NASDAQ:AGIO) stock is trading lower after the update on the sickle cell disease program. The company shared top-line results from its Phase 2 study evaluating tebapivat in patients with sickle cell disease. Despite seeing improvements in hemoglobin levels, the commercial-...
07-21 23:44
Danaher Posts Q2 Results, Joins Calix, Equifax And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session
U.S. stock futures were higher this morning, with the Nasdaq 100 futures gaining more than 1% on Tuesday. Shares of Danaher Corp (NYSE:DHR) fell sharply in pre-market trading following second-quarter results. Danaher posted second-quarter adjusted EPS of $1.94, beating market estimates of $1.83. The...
07-21 20:01
美股牛股 | 制药企业CRNX股价狂飙近99%！获福泰制药百亿美元高溢价收购；罕见病药物研究公司AGIO涨18%
制药企业CRNX股价狂飙近99%！获福泰制药百亿美元高溢价收购；罕见病药物研究公司AGIO涨18%，核心产品新药申请获FDA受理；基因治疗药物研发企业NGNE涨13%，公司成功完成新一轮融资>>
07-08 19:19
美股大行评级 | 最高800美元！16家大行首予SpaceX"买入"或"超配"评级；奥本海上调康宁目标价从210美元升至230美元
今日重点评级关注：Canaccord Genuity：维持AtaiBeckley"买入"评级，目标价从15美元升至17美元；Truist Securities：维持NUVATION BIO"买入"评级，目标价从12美元升至13美元
07-08 15:31
Why Is Agios Pharma Stock Soaring Tuesday?
The U.S. Food and Drug Administration (FDA) has accepted Agios Pharmaceuticals Inc.’s (NASDAQ:AGIO) supplemental New Drug Application (sNDA) for mitapivat, an oral pyruvate kinase (PK) activator, in sickle cell disease with a Priority Review. Following the announcement, the stock jumped by more than...
07-08 02:27
